Product image of Mirabegron Stada (Mirabegron) supplied by GNH India

Mirabegron Stada

Active Ingredient:
Mirabegron
Origin:
EU

Mirabegron Stada (Mirabegron)

Mirabegron, the active ingredient in Mirabegron Stada, is a β3‑adrenergic receptor agonist presented as an oral tablet for oral use. It treats overactive bladder symptoms such as urinary urgency, frequency and incontinence in adult patients.
GNH India supplies Mirabegron Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Stada Arzneimittel Ag

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Mirabegron is indicated for conditions affecting bladder storage function within the overactive bladder disease family.

  • Overactive bladder: reduces urgency episodes and increases bladder capacity.
  • Urinary urgency: lessens sudden strong urges to void.
  • Urinary frequency: decreases the number of daily voids, improving quality of life.

How It Works

  • Mirabegron activates β3‑adrenergic receptors located on the detrusor smooth muscle of the bladder. Receptor activation stimulates cyclic AMP production, leading to relaxation of the detrusor wall during the storage phase, which increases functional bladder capacity and reduces involuntary contractions.

Side Effects

Adverse reactions may occur with mirabegron therapy.

Common Side Effects

  • Hypertension: elevated blood pressure readings.
  • Nasopharyngitis: mild upper respiratory tract infection symptoms.
  • Urinary tract infection: signs of bladder infection.
  • Headache: mild to moderate head pain.
  • Constipation: reduced bowel movements.
  • Dry mouth: decreased salivation.

Serious or Rare Side Effects

  • Urinary retention: difficulty emptying the bladder.
  • Tachycardia: rapid heart rate.
  • Severe hypertension: markedly high blood pressure requiring medical attention.
  • Angioedema: swelling of face, lips or throat.
  • Allergic reactions: rash, itching or anaphylaxis.

Precautions & Warnings

Before initiating therapy, consider the following safety measures.

  • Renal impairment: assess kidney function and adjust dose if necessary.
  • Hepatic impairment: monitor liver enzymes and consider dose modification.
  • Cardiovascular disease: observe blood pressure and heart rate regularly.
  • Concomitant anticholinergics: evaluate additive urinary effects.
  • Pregnancy and lactation: safety not established; use only if clearly needed.
  • Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Mirabegron may interact with other medicines; review patient medication lists.

Major Interactions (Avoid)

  • Strong CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): can increase mirabegron exposure.
  • Narrow‑gap antihypertensives (e.g., beta‑blockers): may reduce blood‑pressure‑lowering effect.
  • Monoamine oxidase inhibitors: risk of hypertensive crisis.

Moderate Interactions (Monitor Closely)

  • Diuretics: may enhance hypotensive response.
  • Anticholinergics: additive effect on urinary retention.
  • Other β3‑agonists: potential for overlapping pharmacodynamic activity.

Frequently Asked Questions

Mirabegron Stada is prescribed to manage symptoms of overactive bladder, including urinary urgency, frequency and urge incontinence. By improving bladder storage capacity, it helps patients achieve better control over voiding patterns and enhances daily comfort.

The drug activates β3‑adrenergic receptors on the detrusor muscle of the bladder. This activation raises cyclic AMP levels, causing the muscle to relax during the filling phase, which expands bladder capacity and reduces involuntary contractions.

The specific dose and titration schedule are determined by the prescribing clinician based on the individual’s medical condition, renal function and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for Mirabegron in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mirabegron belongs to a different class (β3‑adrenergic agonist) and does not have the anticholinergic side‑effects such as dry mouth or constipation that are common with antimuscarinic agents. It may be chosen when anticholinergics are poorly tolerated or contraindicated.

Store the tablets at ambient temperature, preferably below 25 °C. Keep them in the original packaging to protect from moisture and light, and ensure the container is tightly closed when not in use.

Mirabegron Stada is taken orally, usually once daily, with or without food. The tablet should be swallowed whole with a glass of water and not chewed or crushed.

Serious adverse events include significant hypertension, urinary retention, tachycardia and rare allergic reactions such as angioedema. Patients should seek immediate medical attention if they experience severe headache, chest pain, rapid heartbeat or swelling of the face or throat.

Patients with uncontrolled hypertension, severe hepatic impairment, or known hypersensitivity to mirabegron should avoid the medication. Additionally, individuals taking strong CYP2D6 inhibitors or certain antihypertensives should discuss alternatives with their healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Mirabegron

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT